Introduction
Cancer treatments, such as surgery, chemotherapy, radiation therapy, and hormone therapy, cause suffering and distress that lead to impaired quality of life (QoL) for many cancer survivors. The most common problem reported by cancer survivors is cancer-related fatigue (CRF) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Cancer survivors frequently report that CRF begins with diagnosis, worsens during the course of treatment, and per- Mustian, Morrow, Carroll et al. 53 www.TheOncologist.com sists for months, and even years, after treatment is complete . Furthermore, CRF often continues even when the survivor's cancer is undetectable or in remission [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [23] [24] [25] . Survivors with varying cancer diagnoses and receiving different types of treatment report a frequency of CRF in the range of 60%-100%, with 41% or more indicating severe CRF (a score >7 on an 11-point Likert scale where 0 = no CRF and 10 = CRF as bad as you can imagine) during treatment [3] [4] [5] 16, 26, 27] . Moreover, as many as 81% of survivors report persistent CRF, with 17%-38% indicating persistent severe CRF 6 months or longer after completing treatment [11, [27] [28] [29] [30] [31] .
CRF is a multifaceted, subjective, physiological state characterized by persistent, overwhelming exhaustion and a decreased capacity for physical and mental work ( Fig. 1 ) [1] [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [23] [24] [25] 32] . The nature of CRF makes it a symptom that is difficult to define fully. In general, however, CRF is differentiated from the fatigue experienced by healthy individuals by its severity, its impact on the QoL of cancer survivors, and the fact that CRF is not alleviated by rest or sleep [1] [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [23] [24] [25] 32] . The impact of CRF is far reaching. CRF is detrimental to recovery and has a significant negative effect on QoL on a day-to-day basis. The lack of effective remedies adds to the distress cancer survivors must endure because of the inability to alleviate this debilitating symptom [1] [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [23] [24] [25] [32] [33] [34] [35] [36] .
The experience of CRF by cancer survivors involves multiple biopsychosocial signs and symptoms ( Fig. 1 ) that are usually reported by patients as concurrent cancer-or treatment-related side effects [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [23] [24] [25] [37] [38] [39] [40] [41] [42] [43] [44] . Physiological signs and symptoms often include anemia, hypothyroidism, shortness of breath, muscle atrophy, physical weakness, decreased aerobic capacity, sleep disruption, pain, and self-reported tiredness [1, 2, 16, 32] . Mood symptoms include depression and anxiety [1, 2, 16, 32] . Motivational symptoms generally appear as hopelessness or negative outcome expectancies. Cognitive symptoms manifest as impaired memory and the inability to concentrate [1, 2, 16, 32] . Social symptoms generally include a reduction in patients' ability to participate in leisure activities [1, 2, 16, 32, 45] , their capacity to sustain meaningful relationships and activities with their families [1, 2, 16, 32, 46] , their ability to work, and their capacity to engage in social and other activities during and after treatment [1, 2, 16, 32, 47, 48] . No two individuals experience CRF in exactly the same way, making it difficult to develop effective treatments and, most likely, impossible to develop an effective intervention targeted at a single pathopsychological or pathophysiological mechanism that will provide relief for the majority of patients with cancer.
CRF often means that survivors must depend on others for home management, transportation, and even simple self-care activities, such as preparing food or bathing [1, 2, 16, 32, [48] [49] [50] . These changes in daily activity and self-sufficiency may be demoralizing and discouraging. Furthermore, CRF forces patients to engage in unwanted activities in an attempt to cope with their fatigue, such as lying down or taking naps [1, 2, 16, 32, 51] . Importantly, CRF is considered more distressing and has a greater negative impact on patients' daily activities and QoL than other cancer-related symptoms, including vomiting, nausea, pain, and depression [1, 2, 16, 32, 52] . With the improvements and advances in cancer therapy seen in recent years, the impact of CRF is magnified because life expectancy has increased in cancer survivors [1, 2, 11, 16, 24, 32, [53] [54] [55] [56] .
Current Approaches to the Treatment of CRF
The etiology of CRF is complex and multidimensional. The causal contributions of numerous biopsychosocial domains hypothesized to influence CRF are poorly understood and encompass a vast array of potential contributing factors and dynamic psychophysiological pathways. These pos- 
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Oncologist ® sible causes are outlined by Ryan and colleagues [57] . CRF remains underrecognized and undertreated because it is not clearly understood. Indeed, it was not until 1998 that CRF was acknowledged as an official diagnosis in the International Classification of Disease (ICD-10). Subsequently, in 2000, the National Comprehensive Cancer Network (NCCN) published the first set of guidelines synthesizing available research and clinical experience in oncology to provide recommendations for supportive patient care [58] . Since that time, the NCCN Fatigue Practice Guidelines have been updated annually to provide concise, up-to-date recommendations for the management of CRF based on the current understanding of the symptom and the development of new therapies [32] .
The guidelines for the management of CRF currently proposed by the NCCN [32] suggest that clinicians frequently screen for CRF in patients with cancer and, when present, screen for possible contributing factors (e.g., pain, emotional distress, sleep disruption, anemia, nutrition), including comorbid conditions (e.g., infection, cardiac dysfunction, pulmonary dysfunction, renal dysfunction, hepatic dysfunction, neurologic dysfunction, endocrine dysfunction, hypothyroidism). Identifying CRF and its contributing factors does not mean the problem will be alleviated. Clinicians usually treat contributing factors via pharmacologic means (e.g., colony-stimulating factors, antidepressants, steroids, benzodiazepines, benzodiazepine-receptor agonists, thyroid hormones, and psychostimulants) and expect that the CRF will also be resolved [1, 2, 13, 14, 16, 32] . Unfortunately, many patients with cancer continue to experience CRF even after successful clinical treatment of these contributing factors [1, 2, 16, 32, 59, 60] , Additionally, clinicians often encourage patients experiencing CRF to rest and conserve energy, although CRF is not alleviated by periods of rest, as is the case with other types of fatigue [1, 2, 16, 51] . Patients may also experience CRF in the absence of any clinically discernable contributing factors [1, 2, 8, 9, [12] [13] [14] 16] . In instances where no specific causal factors can be identified or when the patient continues to have moderate-to-severe fatigue after addressing these factors, the NCCN guidelines [32] recommend that physicians consider both pharmacologic interventions and integrative nonpharmacologic behavioral interventions.
The NCCN guidelines recommend the use of a variety of integrative nonpharmacologic behavioral interventions, including exercise, psychosocial interventions, and other integrative therapies for the effective management of CRF. This article provides an overview of the scientific evidence for the efficacy of integrative nonpharmacologic behavioral interventions in the management of CRF and makes recommendations for future research.
Integrative Nonpharmacologic Behavioral Interventions
Nonpharmacologic behavioral interventions encompass a wide array of therapeutic modalities with varying levels of scientific evidence supporting their use in the clinical management of CRF. These types of therapeutic interventions are historically referred to as alternative, complementary, traditional, Eastern, or integrative therapies, depending on cultural context and professional discipline. Since the primary focus of this article is to summarize the evidence regarding the merits of supportive care interventions to be used in conjunction with treatments for cancer, all nonpharmacologic behavioral therapies discussed hereafter are generally referred to as integrative therapies. The integrative nonpharmacologic behavioral interventions discussed in this article are organized into three main categories: (a) exercise, (b) psychosocial interventions, and (c) other integrative therapies (Fig. 2 ).
Exercise Interventions
Physical activity is defined as any skeletal muscle movement that causes an increase in energy expenditure above a resting basal metabolic rate and encompasses a wide variety of lifestyle and occupational activities [61] . Exercise is more specifically defined as physical activity performed in a systematically dosed manner (e.g., a specific frequency, intensity, duration, and mode) with the intention of improving health-related outcomes, such as cardiovascular fitness, www.TheOncologist.com muscular strength, body composition, depression, anxiety, sleep, cognition, and fatigue [61] . In the current article, the term exercise or physical exercise is used to describe any physical activity intervention designed and delivered with the intention of improving CRF.
Physical exercise is an integrative nonpharmacologic behavioral intervention that shows great promise in mitigating the acute CRF experienced by cancer patients during treatment, as well as the persistent CRF they experience after treatments are complete. Galvao and Newton [62] , Knols and colleagues [63] , Stevinson and colleagues [64] , Schmidtz and colleagues [65] , and McNeely and colleagues [66] recently summarized the evidence from over 45 studies, reported in 64 published papers , demonstrating positive benefits from physical exercise interventions implemented with cancer survivors during and after treatment. Eight additional published studies [131] [132] [133] [134] [135] [136] [137] [138] , not included in these reviews, also demonstrated positive effects from physical exercise interventions during and after treatments for cancer. The main outcomes examined included CRF, emotional distress (e.g., depression, anxiety), QoL, aerobic capacity, muscular strength, flexibility, body composition, functional capacity, and immunological parameters. Twelve of these studies assessed CRF as a primary or secondary outcome and employed a randomized, controlled clinical trial experimental design. The current article restricts discussion of studies involving exercise interventions to these 12 randomized controlled clinical trials (Table 1) [74, 81, 89, [104] [105] [106] [107] 117, 124, 128, 131, 132] .
Collectively, the results of these 12 studies provide preliminary evidence that exercise is safe and well tolerated by cancer survivors with various cancer diagnoses. The studies also suggest the results are similar for patients throughout the cancer care continuum, postsurgery or post-transplant, as well as during and after chemotherapy, radiation therapy, and/or hormone therapy. One study also suggests that low-intensity seated exercise is safe and well tolerated even by women with metastatic breast cancer. Additionally, this research suggests that exercise interventions involving moderately intense (55%-75% of heart rate maximum) aerobic exercise (e.g., walking and cycling) ranging from 10-90 minutes in duration, 3-7 days/week are consistently effective at either reducing or halting the progression of CRF in cancer patients during and after treatment. Furthermore, one study showed that progressive resistance training (three times per week, 85% -90% of one-repetition maximum, progressively increasing sets and repetitions) was effective in reducing CRF in cancer patients receiving hormone therapy. Lastly, a recent meta-analysis by Schmitz and colleagues [65] suggests that the evidence for exercise as an effective therapy for managing CRF is indeed consistently positive, although the effect size (ES) is small (weighted mean ES = 0.13, 95% confidence interval [CI], -0.06 to 0.33 during treatment; weighted mean ES = 0.16, 95% CI, -0.23 to 0.54 post-treatment), indicating the need for developing more effective exercise interventions.
Although the extant exercise and cancer control literature provides consistent support for the efficacy of exercise interventions in managing CRF during and after treatment, this body of literature is preliminary. The studies have small sample sizes and lack consistency in the type and amounts of exercise used. These limitations make it impossible to apply the results effectively as specifically tailored exercise prescriptions that best meet the needs of the patient. There are also methodologic concerns. The measures used to assess CRF and control groups are inconsistent, making interpretations and conclusions across studies difficult. Appropriate statistical and follow-up analyses were not commonly used (e.g., intent-to-treat analyses in randomized controlled trials), making comparisons based on regimen and methods of exercise intervention difficult to ascertain [62] [63] [64] .
Despite these limitations, this growing body of research provides consistent preliminary support for the safety of exercise interventions for cancer survivors across the entire cancer care continuum.
Psychosocial Interventions
During the last 20 years the body of knowledge regarding the benefits of psychosocial interventions for cancer survivors has grown substantially. Psychosocial interventions include activities such as support interventions (either individually or in groups), education, stress management, coping strategy training, and behavioral interventions designed to assist survivors with managing their CRF. Psychosocial interventions may be particularly useful for cancer survivors in whom exercise is contraindicated, or as an adjunct to exercise programs. As with exercise interventions, a growing body of empiric data supports the use of psychosocial interventions for the management of CRF. Randomized, controlled clinical trials have examined a variety of psychosocial interventions in cancer survivors during and after treatment (Table 2 ) [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] .
Taken together, the results of these studies suggest that psychosocial support therapy portends lower levels of CRF among patients undergoing treatment and cancer survivors with different cancer diagnoses. Additionally, this research suggests that psychosocial interventions are effective in helping to manage CRF whether delivered individually or in a group setting, orally or written, and, interestingly, by a licensed professional or a trained nonprofessional. Furthermore, the benefits may continue for many months following cessation of the interventions [141] . However, interventions that are too lengthy and that require too many sessions during the time when patients are receiving treatments for their cancer, such as radiation, may in fact exacerbate CRF [153] . Unfortunately, the wide variety of psychosocial interventions and the lack of detailed descriptions of the interventions limit the ability to make a differential or overall assessment of the efficacy of psychosocial interventions. As is evident from Table 2 , studies used varying combinations of psychosocial intervention techniques and investigated the effects on CRF using a wide range of assessment tools. Despite the diverse array of psychosocial interventions, in general, the results from these studies suggest that psychosocial interventions benefit patients with cancer both during and after the completion of treatments by improving CRF. However, further research is needed to delineate the optimal mode of delivery, as well as the optimal content for psychosocial interventions targeted at managing CRF.
Other Integrative Interventions
In an attempt to mitigate the unpleasantness of treatment side effects, including CRF, patients with cancer and survivors are increasingly turning to integrative nonpharmacologic behavioral interventions that have not typically been considered part of western European medicine [154] [155] [156] [157] . The most common forms of integrative modalities used by cancer survivors across the U.S. include prayer, relaxation, and exercise [157] . A brief summary follows of the evidence for the merits of yoga, mindfulness-based stress reduction (MBSR), nutrition, sleep, polarity, and restorative therapies for managing CRF.
Yoga
One particular type of exercise intervention, collectively known as yoga, is based on Eastern traditions from India (i.e., classical, Advaita Vedanta, Tantra), Tibet (i.e., Tibetan), and China (i.e., Chi Kung, Tai Chi) [158, 159] . The word yoga is derived from its Sanskrit root, "yuj," which literally means "to yoke" or join together. In this case, yoga refers to a joining of the mind and the body. The earliest forms of yoga were firmly rooted in introspective and meditative practices based on Vedic, Upanishad, and Sutra texts. These early forms ultimately led to what is known today as classical yoga. The system of classical yoga, based largely on the yoga sutras, combines physical exercise with mindfulness, and is the most common style of yoga taught today in the West [158] [159] [160] . In an effort to alleviate side effects, such as CRF, and improve QoL, patients with cancer are turning to yoga with promising results.
Cohen [158] demonstrated no increase in CRF among 39 patients with lymphoma actively receiving treatment, or within 12 months post-treatment, who participated in a Tibetan yoga stress reduction program once a week for 7 weeks. The program included yoga postures, visualization, breathing, and mindfulness. Participants in the waitlist control demonstrated increases in CRF. This is the first published study to report the effect of yoga on CRF using a validated measure (Brief Fatigue Inventory). While results of the study are very encouraging and suggest that yoga may be a viable therapeutic intervention for improving CRF, the evidence remains preliminary. However, this study strongly suggests the need for appropriately powered, randomized controlled trials with CRF as a primary outcome in order to develop a scientific evidence base supporting the use of yoga for the clinical management of CRF [161, 162] .
MBSR
Mindfulness-based stress reduction (MBSR) is a multimodal program focused on improving well-being and health [163] . The most widely recognized MBSR program was developed by Kabat-Zinn [163] at the Massachusetts Medical Center. The program includes one 90-minute session per week for 8 weeks, along with a 3-hour silent retreat between weeks 6 and 7. The curriculum consists of three major components: (a) experiential practice of gentle Hatha yoga (including yoga stretches, poses, and breathing and meditation exercises) performed once a week during the 90-minute sessions and at home; (b) educational materials related to mindfulness, relaxation, meditation, and yoga; and (c) group processing and discussion.
Speca and colleagues [164] demonstrated greater reductions in CRF among 109 early-or late-stage cancer patients participating in an MBSR program compared with participants in a wait-list control group. Additionally, Carlson and colleagues [165, 166] reported improvements in CRF from preintervention to postintervention among 59 patients with breast or prostate cancer participating in an 8-week MBSR program. Both intervention programs were modeled after the Massachusetts Medical Center program headed by Kabat-Zinn [163] . The yoga portion of the intervention included gentle Hatha yoga stretches and poses and breathing and meditation exercises performed once a week as part of the 90-minute class. These are the first two published studies to report on the effect of MBSR on CRF. Again, while results of these studies are positive and suggest that MBSR may be a useful therapeutic intervention for improving CRF, the evidence is preliminary. There is a need for appropriately powered, randomized controlled trials with CRF as a primary outcome to create an informed scientific evidence base upon which to base clinical care.
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Nutritional Therapy
Patients with cancer are at risk for malnutrition and other nutrition-related problems as a result of the cancer itself, the body's response to the cancer, and the treatment prescribed. Many factors may contribute to malnutrition, including nausea, vomiting, mucositis, diarrhea, and malabsorption of food. Clinical manifestations of malnutrition include fatigue, anorexia, weight loss, and muscle wasting, resulting in poor patient outcomes, including a negative effect on recovery and survival. Importantly, malnutrition and other nutrition-related problems may contribute to the development and exacerbation of CRF. In a recent randomized controlled trial in 111 patients with colorectal cancer undergoing radiation therapy, Ravasco and colleagues [167] reported lower CRF among participants assigned to the individualized dietary counseling group and those assigned to the protein-supplement group compared with individuals in the ad libitum food intake group. Patients who received protein supplements did not experience the same reduction in CRF as those receiving dietary counseling who were consuming ordinary foods. The results from this trial are encouraging and they represent the first preliminary evidence that concurrent individualized dietary counseling, based on regular foods, is an effective means of improving patients' nutritional intake and CRF. However, further research is needed to establish a solid scientific evidence base regarding the benefits of nutritional therapy on CRF.
Sleep Therapy
Although patients with CRF frequently report disruptions in their sleep patterns, the relationship between sleep patterns and CRF is not well understood [168, 169] . Healthcare professionals frequently recommend rest and sleep for the management of CRF [168] . One approach that is recommended for the management of sleep disorders is improved sleep hygiene [170] . The rationale behind this approach is that the often self-perpetuating nature of sleep problems means they can be a continuing cause of fatigue. Patients who sleep poorly often extend their overall period of sleep by taking naps, going to bed earlier, or getting up later. This extended "sleep opportunity" can be problematic, however, if it exceeds the basal ability of the body to generate sleep. The resulting reduction in nocturnal sleep quality increases the likelihood that patients will feel fatigue during the day and the cycle continues to repeat itself. Sleep interventions provide patients with guidance on good sleep hygiene (e.g., encouraging patients to go to sleep at the same time each evening and to rise at a similar time every morning). Other sleep interventions limit the overall time spent in bed, the duration of daytime naps, and evening stimulation [171] . Support for the utility of sleep hygiene in the management of CRF is limited by the lack of randomized controlled investigations in this area, although some preliminary positive evidence exists from nonrandomized, noncontrolled studies. Graydon and colleagues [172] observed improvements in CRF among cancer survivors who practiced rest and sleep to manage their symptoms. However, a wide variety of sleep scores were measured among patients adopting similar strategies, suggesting involvement of other factors. More recently, Berger and colleagues [171] reported that a sleep-management intervention in patients undergoing breast cancer chemotherapy resulted in improvements in CRF during the first three chemotherapy cycles, but not during the fourth cycle. Additionally, Savard and colleagues [173] reported significant differences in CRF from pre-to postintervention among breast cancer survivors receiving cognitive behavioral therapy for insomnia compared with survivors in a wait-list control condition. While these results may seem promising, they do not provide sufficient evidence to support the efficacy of sleep therapy for mitigating CRF and further research is needed.
Polarity Therapy
Polarity therapy is an energy therapy, developed by Dr. Randolph Stone in 1947, that employs gentle human touch in an effort to balance the electrical energy fields of living organisms and, thus, portend a state of well-being and health [174] . This "energy therapy" is based in historical Greek, Indian, Egyptian, and Chinese medical traditions. Roscoe and colleagues [174] published the first randomized, controlled pilot study investigating the efficacy of polarity therapy for improving CRF. This study reported that breast cancer survivors receiving one 75-minute session or two 75-minute sessions (a week apart) of polarity therapy during the course of radiation therapy demonstrated significant reductions in CRF compared with survivors receiving standard radiation therapy alone [174] . These results are very encouraging, especially considering this is an integrative nonpharmacologic behavioral intervention that does not require substantial lifestyle change on the part of the cancer survivor. However, this is the only published study to investigate the efficacy of polarity therapy for improving CRF and the study was conducted with a very small sample (n = 15). As such, further randomized controlled trials are needed to establish the efficacy of polarity therapy for improving CRF and create a solid evidence base upon which to inform clinical practice.
Restorative Therapy
Decreased attention capacity, or attentional fatigue, represents one aspect of the sensory dimension of CRF that has been documented in patients with cancer [175] . 
Conclusion
In line with guidelines from the NCCN, integrative nonpharmacologic behavioral treatment should be implemented for the effective management of CRF. A wide range of these interventions is available, including physical exercise, psychosocial therapy, yoga, MBSR, and nutritional, sleep, polarity, and restorative therapies. Physical exercise and psychosocial therapeutic interventions currently have the strongest scientific evidence base to support their use. Unfortunately, the most effective exercise prescription or psychosocial therapy remains unclear and the effect sizes are small. This means that while oncologists can and should encourage their patients to exercise and participate in psychosocial therapy to improve their symptoms and side effects, they cannot provide specific exercise or psychosocial prescriptions for the effective treatment of CRF, and hence, even with exercise and psychosocial therapy, the improvements in CRF may be small. As a result, exercise and psychosocial interventions as part of clinical care for symptom and side-effect management in oncology are not as effective or efficient as they should be. There is also promising, but very limited, evidence to support the use of other integrative nonpharmacologic behavioral interventions for the management of CRF, including yoga, MBSR, and nutritional, sleep, polarity, and restorative therapies. However, the scientific evidence underlying these interventions is very preliminary and the use of these modalities as part of standard clinical care in oncology for the management of CRF is premature.
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Integrative nonpharmacologic behavioral interventions are already sought and used by many patients with cancer to aid in the management of their cancer-and treatment-related symptoms and side effects, such as CRF. The scientific community must continue conducting and funding research to provide the detailed scientific evidence and resources necessary for oncologists to prescribe these types of integrative nonpharmacologic behavioral interventions effectively as part of standard care and to assist cancer survivors in choosing which intervention will best suit their needs. While much is still to be discovered, integrative nonpharmacologic behavioral interventions show great promise in the battle against CRF and its life-altering effects.
